Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Outcome evaluation of an intervention to improve the effective and safe use of meropenem.

Yagi Y, Okazaki M, Higaki H, Nakai M, Hirata A, Miyamura M.

Int J Clin Pharm. 2014 Jun;36(3):648-56. doi: 10.1007/s11096-014-9949-2. Epub 2014 Apr 20.

PMID:
24748508
3.

Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.

Dunn K, O'Reilly A, Silke B, Rogers T, Bergin C.

Int J Clin Pharm. 2011 Apr;33(2):208-14. doi: 10.1007/s11096-010-9475-9. Epub 2011 Jan 25.

PMID:
21744190
4.

Evaluation of a pharmacokineticpharmacodynamic approach using software to optimize the carbapenem antibiotic regimen.

Ishihara N, Nishimura N, Tamaki H, Karino F, Miura K, Isobe T, Ikawa K, Morikawa N, Naora K.

Int J Clin Pharmacol Ther. 2015 Jun;53(6):422-9. doi: 10.5414/CP202191.

PMID:
25828635
5.

Incorporating pharmacy student activities into an antimicrobial stewardship program in a long-term acute care hospital.

Benson JM.

Am J Health Syst Pharm. 2014 Feb 1;71(3):227-30. doi: 10.2146/ajhp130321.

PMID:
24429017
6.

Effects of pharmaceutical counselling on antimicrobial use in surgical wards: intervention study with historical control group.

Grill E, Weber A, Lohmann S, Vetter-Kerkhoff C, Strobl R, Jauch KW.

Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):739-46. doi: 10.1002/pds.2126. Epub 2011 Mar 30.

PMID:
21452339
7.

Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.

Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R.

Ann Pharmacother. 2009 Oct;43(10):1598-605. doi: 10.1345/aph.1M187. Epub 2009 Sep 23.

PMID:
19776297
8.

Streamlining antimicrobial therapy through pharmacists' review of order sheets.

Briceland LL, Lesar TS, Lomaestro BM, Lombardi TP, Gailey RA, Kowalsky SF.

Am J Hosp Pharm. 1989 Jul;46(7):1376-80.

PMID:
2757043
9.

Efficacy and safety of meropenem (3 g daily) in Japanese patients with refractory respiratory infections.

Kawanami T, Mukae H, Noguchi S, Yamasaki K, Akata K, Ishimoto H, Matsumoto K, Morita K, Yatera K.

J Infect Chemother. 2014 Dec;20(12):768-73. doi: 10.1016/j.jiac.2014.08.011. Epub 2014 Sep 2.

PMID:
25193038
10.

Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.

Patel GW, Duquaine SM, McKinnon PS.

Pharmacotherapy. 2007 Dec;27(12):1637-43.

PMID:
18041884
11.

[Effects of early pharmacist intervention on antimicrobial therapy for severe hospital-acquired pneumonia].

Imaura M, Yokoyama H, Kohata Y, Igarashi T, Takahashi H, Kanno H, Yamada Y.

Yakugaku Zasshi. 2013;133(2):283-8. Epub 2012 Dec 5. Japanese.

13.

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.

Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.

Clin Ther. 2008 May;30(5):868-83. doi: 10.1016/j.clinthera.2008.04.019.

PMID:
18555934
14.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
15.

The effect of renal dysfunction on antimicrobial use measurements.

Zagorski BM, Trick WE, Schwartz DN, Wisniewski MF, Hershow RC, Fridkin SK, Weinstein RA.

Clin Infect Dis. 2002 Dec 15;35(12):1491-7. Epub 2002 Dec 2.

PMID:
12471568
16.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
17.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

18.

Pharmacokinetics of sparfloxacin in patients with renal impairment.

Dorr MB, Johnson RD, Jensen B, Magner D, Marbury T, Talbot GH.

Clin Ther. 1999 Jul;21(7):1202-15.

PMID:
10463518
19.

The relationship between the daily dosage of the carbapenem meropenem (MEPM) and MEPM-resistant Pseudomonas aeruginosa.

Harashima S, Kondo H, Nabeshima A, Shimoda M, Yamaji K, Horiuchi T, Shimono N, Ikematsu H.

J Infect Chemother. 2008 Jun;14(3):219-22. doi: 10.1007/s10156-008-0601-8. Epub 2008 Jun 24.

PMID:
18574658
20.

Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit.

Jiang SP, Zhu ZY, Ma KF, Zheng X, Lu XY.

Scand J Infect Dis. 2013 Dec;45(12):891-9. doi: 10.3109/00365548.2013.827338. Epub 2013 Sep 12.

PMID:
24024759

Supplemental Content

Support Center